Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 August, 2017 10:45 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Dr Reddy's to get up to USD 32.5 mn in milestone payments for DFD-06 - 22-Aug-2017 10:33
Eros International Media's promoter completes sale of 11.8 mn shares - 22-Aug-2017 10:22
ONGC receives nod to acquire government's 51.11% stake in HPCL - 22-Aug-2017 10:19
ONGC receives nod to acquire government's 51.11% stake in HPCL - 22-Aug-2017 10:19
HCL Infosystems to distribute Apple products in Indian market - 22-Aug-2017 10:05
Lupin receives EIR from USFDA for Aurangabad facility - 22-Aug-2017 10:02
McNally Bharat bags order worth Rs 5.14 bn - 22-Aug-2017 09:58
TCS' arm to deploy digital learning platform for ICSI - 21-Aug-2017 16:09
India's microfinance sector growth slows down to 29% in FY17: ICRA - 21-Aug-2017 16:04
Jubilant receives NDA approval for Drax Exametazime - 21-Aug-2017 15:07
Tata Power launches electric vehicle charging infrastructure in Mumbai - 21-Aug-2017 13:54
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer